Duff & Phelps Advised the Special Committee of the Board of Directors of Xtant Medical Holdings, Inc. (NYSE American: XTNT) in Its Debt Restructuring Transaction

or to bookmark this page

Click here to bookmark this page

Click here to remove bookmark

has completed a debt for equity exchange as part of a restructuring transaction

Duff & Phelps Advised the Special Committee of the Board of Directors of Xtant Medical Holdings, Inc. (NYSE American: XTNT) in Its Debt Restructuring Transaction

Contact Us

On August 10, 2020, Xtant Medical Holdings, Inc. (NYSE American: XTNT) ("the Company"), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has entered into a Restructuring and Exchange Agreement with the lenders under its credit facility to restructure Xtant’s outstanding indebtedness, including the exchange of certain indebtedness outstanding under the facility, together with accrued and unpaid interest thereon, into shares of Xtant common stock.

The primary purpose of the restructuring is to improve Xtant’s capital structure by reducing its outstanding debt, which the Company expects will facilitate future access to capital markets for investment in its growth initiatives, and provide a path to possibly regain compliance with the NYSE American continued listing standards.

Duff & Phelps served as a financial advisor to the special committee of the board of directors of Xtant Medical Holdings, Inc.and provided a fairness opinion in connection with the transaction.

About Xtant Medical Holdings, Inc. 
Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Fox Rothschild LLP served as legal counsel to Xtant Medical Holdings, Inc. and Stoel Rives LLP served as legal counsel to the special committee.

2020-08-12T00:00:00.0000000 /-/media/assets/images/transactions/2020/xtant-medical.jpg /about-us/transactions/fairness-opinions/fairness-opinion-xtant-medical-holdings-inc case study {D59CA77E-C551-45A3-BE89-F567210C5A60} {6B6F3B01-98A6-4BC2-B2CD-CBD127447FB5} {49ED5FA4-1B37-4C7A-8D38-6861240EC2CC} {4DACD310-421A-42AC-BEF4-8AA7E70484CD} {D3AE3EC6-3254-4441-B111-1AF8D558906C} {5CE144D0-ADDC-43A3-95E4-3428CA819BF8} {DF0A8D82-EB98-4261-8951-BF842E034FA8} {B871D4F9-5FCB-40B9-8710-871A30B710AB}

Other Areas We Can Help

Corporate Finance

Comprehensive support throughout mergers and acquisitions and other corporate transactions.

Corporate Finance

Comprehensive Due Diligence Solution

Comprehensive diligence support primarily in the areas of tax, compliance and regulatory, operations, financial and accounting, investigations and disputes and cyber/IT risk.

Comprehensive Due Diligence Solution

M&A Advisory

Middle-market M&A advisory differentiated by industry expertise and superior deal execution.

M&A Advisory

Transaction Advisory Services

Seamless analytical advisory through the deal continuum, from transaction origination to closing.

Transaction Advisory Services

Private Capital Markets

Senior, subordinated and mezzanine debt and venture/private equity for a wide range of transactions.

Private Capital Markets

Related Case Studies

Insights

Valuation

2021 Study of Professional Golfers’ Future Career Value

Valuation
M&A Advisory

Healthcare Services Sector Update – April 2021

M&A Advisory
M&A Advisory

Staffing Industry M&A Landscape – Spring 2021

M&A Advisory
M&A Advisory

Healthcare Services Sector Update – March 2021

M&A Advisory

News